| GEMOX: Oxaliplatin in Pancreatic Cancer (NCT00261092) | Sanofi | 2005-10-01 |
| Immunogenicity and Safety of Pentaxim in South African Infants (NCT00254969) | Sanofi | 2005-10-01 |
| Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine (NCT00518427) | Sanofi | 2005-10-01 |
| ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus. (NCT00272064) | Sanofi | 2005-10-01 |
| Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr (NCT00232310) | Sanofi | 2005-10-01 |
| Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients (NCT00271284) | Sanofi | 2005-10-01 |
| Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (NCT00252356) | Sanofi | 2005-09-01 |
| Irbesartan in Hypertension (NCT00265967) | Sanofi | 2005-09-01 |
| Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (NCT00252330) | Sanofi | 2005-09-01 |
| Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid. (NCT00174720) | Sanofi | 2005-09-01 |
| Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults (NCT00258947) | Sanofi | 2005-09-01 |
| Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder (NCT00855530) | Sanofi | 2005-09-01 |
| Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder (NCT00252343) | Sanofi | 2005-09-01 |
| Lantus Effect on Myocardial Glucose Metabolism in T2 (NCT00335465) | Sanofi | 2005-09-01 |
| Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant (NCT00228176) | Sanofi | 2005-08-01 |
| Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2) (NCT00135941) | Sanofi | 2005-08-01 |
| ALF-ONE : ALFuzosin ONcE Daily (NCT00280605) | Sanofi | 2005-08-01 |
| APIDRA Registration Study (NCT00489190) | Sanofi | 2005-08-01 |
| ACT MALI: Treatment of Malaria Based on Combination Therapies (NCT00452907) | Sanofi | 2005-07-01 |
| Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers (NCT00127803) | Sanofi | 2005-07-01 |
| Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (NCT00264914) | Sanofi | 2005-07-01 |
| Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled Corticosteroid (NCT00174733) | Sanofi | 2005-07-01 |
| A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation (NCT00174785) | Sanofi | 2005-06-01 |
| Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLerance (NCT00445796) | Sanofi | 2005-06-01 |
| Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear Infections (NCT00174811) | Sanofi | 2005-06-01 |
| Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension (NCT00263003) | Sanofi | 2005-06-01 |
| Rasburicase for Hyperuricemia (NCT00290992) | Sanofi | 2005-06-01 |
| Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS (NCT00232297) | Sanofi | 2005-06-01 |
| SOLIACS: Solian Solution in the Acute Setting (NCT00245674) | Sanofi | 2005-06-01 |
| Drotaverine in Dysmenorrhoea Treatment (NCT00292747) | Sanofi | 2005-05-25 |
| ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC) (NCT00424853) | Sanofi | 2005-05-01 |
| A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX (NCT00319592) | Sanofi | 2005-05-01 |
| MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence. (NCT00174798) | Sanofi | 2005-05-01 |
| A Fifty-two-week Study to Evaluate the Safety of Saredutant in Adult and Elderly Patients With Depression (NCT00250653) | Sanofi | 2005-05-01 |
| Insulin Glargine During and After the Period of Fasting in Ramadan (NCT00258804) | Sanofi | 2005-05-01 |
| ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week (NCT00544180) | Sanofi | 2005-05-01 |
| An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese Patients (NCT00239967) | Sanofi | 2005-05-01 |
| Japanese Study of the Combined Administration of Docetaxel With Prednisolone for Metastatic Hormone Refractory Prostate Cancer (NCT00723086) | Sanofi | 2005-05-01 |
| Docetaxel in Non Small Cell Lung Cancer (NSCLC) (NCT00263016) | Sanofi | 2005-05-01 |
| Amisulpride in Schizophrenic Acute Phase Patients (NCT00436371) | Sanofi | 2005-05-01 |
| Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients (NCT00271323) | Sanofi | 2005-05-01 |
| DILIPO (DILutIonal HyPOnatremia) (NCT00274326) | Sanofi | 2005-05-01 |
| An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression (NCT00250614) | Sanofi | 2005-04-01 |
| Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study (NCT00232258) | Sanofi | 2005-04-01 |
| Insulin Glargine in Type 2 Diabetes Mellitus (NCT00272077) | Sanofi | 2005-04-01 |
| APROVE : Irbesartan in Hypertension (NCT00283036) | Sanofi | 2005-04-01 |
| TRACE: Tirapazamine-Radiation And Cisplatin Evaluation (NCT00174837) | Sanofi | 2005-04-01 |
| An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression (NCT00250601) | Sanofi | 2005-04-01 |
| Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents (NCT00115570) | Sanofi | 2005-04-01 |
| EMINEM: Efficacy of Muscoril In NEck Myofascial Syndromes (NCT00272532) | Sanofi | 2005-04-01 |
| Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma (NCT00436800) | Sanofi | 2005-03-01 |
| Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma (NCT00174746) | Sanofi | 2005-03-01 |
| Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients (NCT00257257) | Sanofi | 2005-03-01 |
| Study of the Effect of SR57667B in Patients With Alzheimer's Disease (NCT00285025) | Sanofi | 2005-03-01 |
| CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer (NCT00129870) | Sanofi | 2005-02-01 |
| Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions (NCT00350038) | Sanofi | 2005-02-01 |
| Telithromycin in Respiratory Tract Infections (NCT00261105) | Sanofi | 2005-02-01 |
| Insulin Glulisine, Diabetes Mellitus Type 1 (NCT00397553) | Sanofi | 2005-01-01 |
| STILDEP: Zolpidem in Depressive and Dysthimic Patients (NCT00292734) | Sanofi | 2005-01-01 |
| Safety Study of Sodium Divalproate in Bipolar Disorder in Adolescents (NCT00271258) | Sanofi | 2005-01-01 |
| STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study) (NCT00124332) | Sanofi | 2005-01-01 |
| Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients (NCT00454272) | Sanofi | 2005-01-01 |
| Valproic Acid Sodium Salt in Bipolar Disorder (NCT00431522) | Sanofi | 2004-12-01 |
| Enoxaparin in Acute Venous Thromboembolic Disease (NCT00265993) | Sanofi | 2004-12-01 |
| Opposing Step-by-step Insulin Reinforcement to Intensified Strategy (NCT00174642) | Sanofi | 2004-12-01 |
| Thiocolchicoside Injection and Capsule in Treatment of Acute Low Back Pain (NCT00917436) | Sanofi | 2004-12-01 |
| An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression (NCT00250627) | Sanofi | 2004-12-01 |
| Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter (NCT00233441) | Sanofi | 2004-12-01 |
| An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression (NCT00256113) | Sanofi | 2004-12-01 |
| Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus (NCT00290979) | Sanofi | 2004-12-01 |
| Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction (NCT00123565) | Sanofi | 2004-12-01 |
| Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine (NCT00981630) | Sanofi | 2004-11-01 |
| Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia (NCT00409357) | Sanofi | 2004-11-01 |
| Insulin Glulisine in Diabetes Mellitus, Type 2 (NCT00174668) | Sanofi | 2004-11-01 |
| A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients (NCT00239174) | Sanofi | 2004-11-01 |
| Insulin Glulisine in Type 2 Diabetes Mellitus (NCT00310297) | Sanofi | 2004-11-01 |
| TREAD-20: Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee Pain Due to Osteoarthritis (NCT00130468) | Sanofi | 2004-11-01 |
| CHOOSE : Telithromycin, Acute Bacterial Sinusitis (NCT00174694) | Sanofi | 2004-11-01 |
| Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer (NCT00494338) | Sanofi | 2004-11-01 |
| KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections (NCT00132951) | Sanofi | 2004-10-01 |
| Japanese Dose-Response Study of Rimonabant in Obese Patients (NCT00459004) | Sanofi | 2004-10-01 |
| Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx Carcinoma (NCT00772681) | Sanofi | 2004-10-01 |
| HP184 in Chronic Spinal Cord Injury Subjects (NCT00093275) | Sanofi | 2004-10-01 |
| Efficacy and Safety of Rimonabant as an Aid to Smoking Cessation With or Without Nicotine Patch (NCT00458718) | Sanofi | 2004-09-01 |
| CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease (NCT00174759) | Sanofi | 2004-09-01 |
| Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function (NCT00094965) | Sanofi | 2004-09-01 |
| Glulisine + Lantus in Type I Patients (NCT00546702) | Sanofi | 2004-09-01 |
| Glulisine + Lantus in Type I Patients (NCT00545337) | Sanofi | 2004-09-01 |
| Insulin Glargine in Type 2 Diabetes (NCT00268645) | Sanofi | 2004-09-01 |
| The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention (NCT00133731) | Sanofi | 2004-09-01 |
| To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent (NCT00620100) | Sanofi | 2004-09-01 |
| Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer (NCT00160030) | Sanofi | 2004-09-01 |
| Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis (NCT00134563) | Sanofi | 2004-09-01 |
| PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone (NCT00291005) | Sanofi | 2004-08-01 |
| MASCOT : Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV (NCT00263055) | Sanofi | 2004-08-01 |
| Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin (NCT00135096) | Sanofi | 2004-08-01 |
| Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG) (NCT00425243) | Sanofi | 2004-08-01 |
| Efficacy and Safety of Rimonabant on Weight Loss and Frequency of Binge Episodes in Obese Patients (NCT00481975) | Sanofi | 2004-08-01 |
| Japanese Study Evaluating Safety, Efficacy and Acceptability of Telithromycin in Children With Infections (NCT00408135) | Sanofi | 2004-08-01 |
| Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment (NCT00087958) | Sanofi | 2004-08-01 |